HomeSearchExpert Review of Neurotherapeutics

Expert Review of Neurotherapeutics

Taylor and Francis Ltd. · United Kingdom · Est. 1983

ISSN1473-7175eISSN1744-8360
SJR Q1WOS SCIEScopus / SJR
60
/ 100
Medium Risk
Score Breakdown
WoS SCIE/SSCI+25
Scopus Q1+25
Total60
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
SJR Score
1.162
H-Index
124
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIP
1.044
Total Works
3,384
Total Citations
96,535
2yr Mean Citedness
3.41
Free JIF alternative
Retractions
1
Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal focuses on neurotherapeutics, covering the development and review of treatments for neurological and psychiatric disorders. It examines pharmacologic therapies, including monoclonal antibodies and novel drug formulations, as well as non-pharmacologic interventions like neuromodulation and psychological therapies. The scope also includes the evaluation of treatment resistance, diagnostic challenges, and the role of biomarkers and genetic factors in therapeutic response across conditions such as migraine, depression, neuropathies, epilepsy, and neurodegenerative diseases.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Q1
SJR Rank
Top 25% in field

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1983
FrequencyTwelve No. A Year, 2009-
StatusActive (last: 2026)
Total Publications3,384
Publisher OrgTaylor & Francis
Visit Journal Website

Submission Info

Peer Review
Review Time
Acceptance Rate
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/12 · 50%
Do you know the journal / publisher?
Taylor and Francis Ltd.
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1473-7175 / 1744-8360
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Neurology (clinical)Q1
Pharmacology (medical)Q1
Neuroscience (miscellaneous)Q2

Subject Classification

Web of Science Categories

Clinical NeurologyPharmacology & Pharmacy

Scopus Categories

Neuroscience (miscellaneous)Pharmacology (medical)Neurology (clinical)

Research Topics (OpenAlex)

Neurological disorders and treatmentsEpilepsy research and treatmentParkinson's Disease Mechanisms and TreatmentsMultiple Sclerosis Research StudiesMigraine and Headache StudiesBipolar Disorder and TreatmentPharmacological Effects and Toxicity StudiesSchizophrenia research and treatmentAlzheimer's disease research and treatmentsGlioma Diagnosis and Treatment
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref